COVID-SEROINDEX

Dead / Abandoned — Abandoned — no statement of use filed (as of 03 Apr 2023)

What this means for you

This application is over — abandoned 03 Apr 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number
90089929
Mark type
Stylized text
Filed
03 Aug 2020
Published for opposition
05 Jul 2022
Abandoned
03 Apr 2023
Attorney of record
Michelle A. Cooke

Goods and services

  • Class 005 — Pharmaceuticals: Diagnostic agents, preparations and substances for medical or veterinary purposes; Medical diagnostic reagents and assays for testing and analysis of blood, bodily fluids, biological and cellular samples and specimens; Reagents for medical use; Clinical medical reagents; Diagnostic assays, reagents, media, solutions and buffers for medical use; Diagnostic agents for carrying out serologic tests for medical purposes; Diagnostic reagents for serologic tests of infections for medical purposes; Diagnostic agents, preparations, substances and diagnostic test kits used for detecting antibodies, enzymes, antigens, diseases, viruses and infections for medical purposes; Test kits consisting of medical diagnostic reagents, assays, solutions and buffers for testing in the field of the prevention and treatment of infections, viruses, disorders and diseases; Diagnostic kits comprised of medical diagnostic reagents and assays for testing and analysis of blood, bodily fluids, biological and cellular samples and specimens for use in infection, virus and disease detection, namely, infectious, viral, communicable, blood-borne pathogen, vector-borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Diagnostic preparations for medical purposes for detecting the presence of infectious, viral, communicable, blood-borne pathogen, vector-borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Medicated, therapeutic and pharmaceutical preparations and substances for the prevention and treatment of SARS-CoV-2, COVID-19, and infectious, viral, communicable, blood-borne pathogen, vector-borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Specimen collection kits for use in medical and clinical testing for the presence of antibodies in blood, biological fluids, bodily fluids, biological and cellular samples and specimens and tissue comprised primarily of assays, reagents, media, solutions, buffers, antibodies, antigens, control materials, membranes, plasma, diagnostic chemicals, calibrators, swabs for medical purposes, plates, vessels, tubes, pipettes, trays, panels, slides, cards and bottles; all the foregoing related to the detection, diagnosis, testing, prevention and/or treatment of SARS-CoV-2, COVID-19 and antibodies, antigens, diseases, illnesses, viruses, disorders and/or infections related to SARS-CoV-2 or COVID-19

Owner

Prosecution history

  • 03 Apr 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
  • 03 Apr 2023 — ABANDONMENT - NO USE STATEMENT FILED
  • 30 Aug 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 05 Jul 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 05 Jul 2022 — PUBLISHED FOR OPPOSITION
  • 15 Jun 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 31 May 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 31 May 2022 — EXAMINER'S AMENDMENT ENTERED
  • 31 May 2022 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
  • 31 May 2022 — EXAMINERS AMENDMENT E-MAILED
  • 31 May 2022 — EXAMINERS AMENDMENT -WRITTEN
  • 14 Nov 2021 — NOTIFICATION OF FINAL REFUSAL EMAILED
  • 14 Nov 2021 — FINAL REFUSAL E-MAILED
  • 14 Nov 2021 — FINAL REFUSAL WRITTEN
  • 27 Aug 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED

View this trademark record on Marksy